Nadroparin Clinical Trials
2 recruitingDrug
Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 3
Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University200 enrolled7 locationsNCT04066764
Recruiting
Phase 3
Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study
May-Thurner Syndrome
Second Affiliated Hospital, School of Medicine, Zhejiang University224 enrolled9 locationsNCT04067505